PO No :PO3276178682-129
Name : Ms.LATIFUN ANSARI Client Name : TATA 1MG OKHLA
Age/Gender : 44/Female Registration Date : 09/Oct/2024 11:05AM
Patient ID : OKH1675088 Collection Date : 09/Oct/2024 10:16AM
Barcode ID/Order ID : D14056259 / 10873171 Sample Receive Date : 09/Oct/2024 01:48PM
Referred By : Dr. Report Status : Final Report
Sample Type : Whole Blood-EDTA Report Date : 09/Oct/2024 08:07PM
HAEMATOLOGY
Test Name Result Unit Bio. Ref. Interval Method
CBC With NLR
Complete Blood Count
Hemoglobin 10.1 g/dL 12.0 - 15.0 Cyanide Free SLS
RBC 3.92 10^6/cu.mm 3.8-4.8 Impedance
HCT 31.6 % 36-46 Calculated
MCV 80.5 fL 83 - 101 RBC pulse measurement
MCH 25.7 pg 27 - 32 Calculated
MCHC 31.9 g/dL 31.5 - 34.5 Calculated
RDW-CV 18.3 % 11.6-14 Calculated
Total Leucocyte Count 6.57 10^3/µL 4 - 10 Impedance
Differential Leucocyte Count
Neutrophils 55.5 % 40-80 DHSS/Microscopy
Lymphocytes 34.1 % 20-40 DHSS/Microscopy
Monocytes 9.2 % 2-10 DHSS/Microscopy
Eosinophils 1.2 % 1-6 DHSS/Microscopy
Basophils 0 % 0-2 Impedance/Microscopy
Absolute Leucocyte Count
Absolute Neutrophil Count 3.65 10^3/µL 2-7 Calculated
Absolute Lymphocyte Count 2.24 10^3/µL 1-3 Calculated
Absolute Monocyte Count 0.6 10^3/µL 0.2-1 Calculated
Absolute Eosinophil Count 0.08 10^3/µI 0.02-0.5 Calculated
Platelet Count 161 10^3/µL 150-410 Impedance /Microscopy
MPV 13.7 fL 6.5 - 12 Calculated
PDW 30.3 fL 9-17 Calculated
Neutrophil Lymphocyte Ratio [NLR]
Neutrophil Lymphocyte Ratio 1.63 1-3
Comment:
As per the recommendation of International council for Standardization in Hematology, the differential leucocyte counts
are additionally being reported as absolute numbers of each cell in per unit volume of blood.
This test has been performed at
TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020
Page 1 of 5
PO No :PO3276178682-129
Name : Ms.LATIFUN ANSARI Client Name : TATA 1MG OKHLA
Age/Gender : 44/Female Registration Date : 09/Oct/2024 11:05AM
Patient ID : OKH1675088 Collection Date : 09/Oct/2024 10:16AM
Barcode ID/Order ID : D14056259 / 10873171 Sample Receive Date : 09/Oct/2024 01:48PM
Referred By : Dr. Report Status : Final Report
Sample Type : Whole Blood-EDTA Report Date : 09/Oct/2024 08:07PM
HAEMATOLOGY
Test Name Result Unit Bio. Ref. Interval Method
Test conducted on EDTA whole blood.
This test has been performed at
TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020
Page 2 of 5
PO No :PO3276178682-129
Name : Ms.LATIFUN ANSARI Client Name : TATA 1MG OKHLA
Age/Gender : 44/Female Registration Date : 09/Oct/2024 11:05AM
Patient ID : OKH1675088 Collection Date : 09/Oct/2024 10:16AM
Barcode ID/Order ID : D12942413 / 10873171 Sample Receive Date : 09/Oct/2024 01:43PM
Referred By : Dr. Report Status : Final Report
Sample Type : Fluoride Plasma F Report Date : 09/Oct/2024 02:28PM
BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method
Glucose - Fasting
Glucose - Fasting 87 mg/dL 70 - 99 Hexokinase
Fasting Plasma Glucose (mg/dL) 2 hr plasma Glucose (mg/dL) Diagnosis
99 or below 139 or below Normal
100 to 125 140 to 199 Pre-Diabetes (IGT)
126 or above 200 or above Diabetes
Reference : American Diabetes Association
Comment:
Impaired glucose tolerance (IGT) fasting, means a person has an increased risk of developing type 2 diabetes but does not
have it yet. A level of 126 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes.
IGT (2 hrs Post meal ), means a person has an increased risk of developing type 2 diabetes but does not have it yet. A 2-hour
glucose level of 200 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes
Plasma Glucose Goals For people with Diabetes
Before meal 70-130 mg/dL
2 Hours after meal Less than 180 mg/dL
Less than 7%
HbA1c
This test has been performed at
TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020
Page 3 of 5
PO No :PO3276178682-129
Name : Ms.LATIFUN ANSARI Client Name : TATA 1MG OKHLA
Age/Gender : 44/Female Registration Date : 09/Oct/2024 11:05AM
Patient ID : OKH1675088 Collection Date : 09/Oct/2024 10:16AM
Barcode ID/Order ID : D14056261 / 10873171 Sample Receive Date : 09/Oct/2024 01:45PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 09/Oct/2024 05:17PM
Immunology
Test Name Result Unit Bio. Ref. Interval Method
Thyroid Stimulating Hormone, Ultrasensitive
Thyroid Stimulating Hormone - Ultra 3.670 uIU/ml 0.55-4.78 CLIA
Sensitive
Comment:
Reference ranges for TSH (μIU/ml) [As per American thyroid
Pregnancy
Association]
1st
0.1-2.5
trimester
2nd
0.2-3.0
trimester
3rd
0.3-3.0
trimester
TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm
.
The variation is of the order of 50%, hence time of the day has influence on the measured serum TSH concentrations.
TSH is secreted in a dual fashion: Intermittent pulses constitute 60-70% of total amount, background continuous secretion
is 30-40%.These pulses occur regularly every 1-3 hrs.
TSH is a very sensitive and specific parameter for assessing thyroid function and is particularly suitable for early detection
or exclusion of disorders in the central regulating circuit between the hypothalamus, pituitary and thyroid.
Changes in thyroid status are typically associated with concordant changes in T3, T4 and TSH levels.
For the diagnosis of hypothyroidism and hyperthyroidism, sole dependence on TSH should not be done and assay needs
to be interpreted with the clinical condition & other investigations.
Serum TSH level changes significantly in response to even minor changes in thyroid hormones.
Transient increase in TSH level or an abnormal TSH levels can be seen in various nonthyroidal diseases.
Unexpectedly abnormal or discordant thyroid test values may be seen with some rare, but clinically significant conditions
such as central hypothyroidism, TSH-secreting pituitary tumors, thyroid hormone resistance, or the presence of
heterophilic antibodies (HAMA) or thyroid hormone autoantibodies.
This test has been performed at
TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020
Page 4 of 5
PO No :PO3276178682-129
Name : Ms.LATIFUN ANSARI Client Name : TATA 1MG OKHLA
Age/Gender : 44/Female Registration Date : 09/Oct/2024 11:05AM
Patient ID : OKH1675088 Collection Date : 09/Oct/2024 10:16AM
Barcode ID/Order ID : D14056261 / 10873171 Sample Receive Date : 09/Oct/2024 01:45PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 09/Oct/2024 05:17PM
Immunology
Test Name Result Unit Bio. Ref. Interval Method
TSH T3 T4 Interpretation
High Normal Normal Subclinical Hypothyroidism
Low Normal Normal Subclinical Hyperthyroidism
High High High Secondary Hyperthyroidism
Low High/Normal High/Normal Hyperthyroidism
Non thyroidal illness / Secondary
Low Low Low
Hypothyroidism
*** End Of Report ***
Conditions of Laboratory Testing & Reporting:
Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should
be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report
may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal
purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com
Disclaimer: Results relate only to the sample received. Test results marked "BOLD" indicate abnormal results i.e. higher or lower than normal. All
lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.
Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the
information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be
vetted by a qualified doctor only.
This test has been performed at
TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020
Page 5 of 5
Ensuring accuracy IN every single report
Following a 3-step review process:
Advanced systems & Experienced lab experts Each report undergoes
cutting-edge technology analyze and technicians conduct rigorous medical scrutiny & is
results with precision comprehensive reviews signed off by a doctor
Have concerns regarding the report?
Reach out to our care team at care@1mg.com
or chat with us
CONNECT NOW >
Accurate Testing, Assured Quality: Diagnostics Precision
Stringent quality control Cutting-edge technology Experienced lab staff
Measures meeting Robust healthcare systems 30+ medical professionals
international norms of safety equipped with calibrated & with a collective
guidelines well-maintained machinery experience of 200+ years
Verified test procedures External assessments Trained phlebotomists
Highly standardized test Thorough third-party Ensuring smooth sample
procedures following CLSI* assessment by authorized collection experience &
guidelines experts pre-analytical precision
Claim FREE doctor consultation
Watch how
Consult top doctors from
the comfort of your home
we take care of
your sample
SCHEDULE NOW>
Get Second Opinion Order Medicines EXPLORE NOW >
Explore Financial Need Help?
Book Lab Tests
Support & more 1800-102-1618
*Clinical & Laboratory Standards Institute T&C Apply
